Improved Process For Production Of Fibrinogen And Fibrinogen Produced Thereby

Patent No. EP2825555 (titled "Improved Process For Production Of Fibrinogen And Fibrinogen Produced Thereby") was filed by Octapharma on Mar 12, 2013. The application was issued on Jul 12, 2017.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
BIOTESTApr 12, 2018TER MEER STEINMEISTER & PARTNER
STRAWMANApr 9, 2018MURGITROYD

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2825555

OCTAPHARMA
Application Number
EP13709190A
Filing Date
Mar 12, 2013
Status
Revoked
Dec 6, 2023
Publication Date
Jul 12, 2017